Desq Long
Sign in

Company

Cytek Biosciences, Inc.

CTKB · CIK 0001831915

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 3,086 shares; price not stated (see filing).

Reporting Person MUIR GLENN P · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001181190-26-000007 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 6,107 shares; price not stated (see filing).

Reporting Person Chin Richard · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001337252-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 2,181 shares; price not stated (see filing).

Reporting Person Holder Michael · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001515140-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 11,781 shares; price not stated (see filing).

Reporting Person Jiang Wenbin · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001872873-26-000006 · filed 2026-08-20 · View filing →

SEC FORM 4
$13,398.23

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 2,869 shares at $4.67 per share.

Reporting Person Jiang Wenbin · Officer Title PRESIDENT AND CEO · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001872873-26-000006 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 22,100 shares; price not stated (see filing).

Reporting Person Jiang Wenbin · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001872873-26-000006 · filed 2026-08-20 · View filing →

SEC FORM 4
$25,133.94

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 5,382 shares at $4.67 per share.

Reporting Person Jiang Wenbin · Officer Title PRESIDENT AND CEO · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001872873-26-000006 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 29,002 shares; price not stated (see filing).

Reporting Person Jiang Wenbin · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001872873-26-000006 · filed 2026-08-20 · View filing →

SEC FORM 4
$32,979.54

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 7,062 shares at $4.67 per share.

Reporting Person Jiang Wenbin · Officer Title PRESIDENT AND CEO · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001872873-26-000006 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 57,212 shares; price not stated (see filing).

Reporting Person Jiang Wenbin · Officer Title PRESIDENT AND CEO · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001872873-26-000006 · filed 2026-08-20 · View filing →

SEC FORM 4
$97,864.52

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 20,956 shares at $4.67 per share.

Reporting Person Jiang Wenbin · Officer Title PRESIDENT AND CEO · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001872873-26-000006 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 7,363 shares; price not stated (see filing).

Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →

SEC FORM 4
$8,303.26

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 1,778 shares at $4.67 per share.

Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 5,525 shares; price not stated (see filing).

Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →

SEC FORM 4
$6,285.82

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 1,346 shares at $4.67 per share.

Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 6,162 shares; price not stated (see filing).

Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →

SEC FORM 4
$7,009.67

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 1,501 shares at $4.67 per share.

Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 14,220 shares; price not stated (see filing).

Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →

SEC FORM 4
$16,172.21

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 3,463 shares at $4.67 per share.

Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 6,320 shares; price not stated (see filing).

Reporting Person McCombe William D. · Officer Title Chief Financial Officer · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001878824-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$9,858.37

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 2,111 shares at $4.67 per share.

Reporting Person McCombe William D. · Officer Title Chief Financial Officer · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001878824-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 13,051 shares; price not stated (see filing).

Reporting Person McCombe William D. · Officer Title Chief Financial Officer · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001878824-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$20,510.64

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 4,392 shares at $4.67 per share.

Reporting Person McCombe William D. · Officer Title Chief Financial Officer · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001878824-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
—

Cytek Biosciences, Inc. (CTKB)

Acquisition (code M) of 16,049 shares; price not stated (see filing).

Reporting Person McCombe William D. · Officer Title Chief Financial Officer · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001878824-26-000004 · filed 2026-08-20 · View filing →

SEC FORM 4
$25,222.67

Cytek Biosciences, Inc. (CTKB)

Disposition (code F) of 5,401 shares at $4.67 per share.

Reporting Person McCombe William D. · Officer Title Chief Financial Officer · Transaction Code F

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001878824-26-000004 · filed 2026-08-20 · View filing →